跳至主要内容
临床试验/EUCTR2006-002295-18-SE
EUCTR2006-002295-18-SE进行中(未招募)不适用

ACT: Avastin and Chemoterapy followed by Avastin alone or in combination with Tarceva for the treatment of metatstatic colorectal cancer - ACT

niversity Hospital Lund, Dept of Oncology, Clinical Trial Unit0 个研究点目标入组 240 人开始时间: 2006年12月27日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Untreated metastatic colorectal carcinoma
  • Age = 18 years
  • Measurable disease according to Response Evaluation Criteria in solid Tumors (RECIST) criteria
  • Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
  • Life expectancy more than 3 months.
  • Adequate haematological, renal and liver function
  • Blood sample and paraffin embedded tumour tissue for translational research
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years)
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years)
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Adjuvant therapy within 6 months
  • Central nervous system (CNS) metastases
  • Clinically significant atherosclerotic vascular disease

研究者

发起方
niversity Hospital Lund, Dept of Oncology, Clinical Trial Unit

相似试验

进行中(未招募)
不适用
ACT: Avastin and Chemotherapy followed by Avastin alone or in combination with Tarceva for the treatment of metastatic colorectal cancer - ACT
EUCTR2006-002295-18-DKniversity Hospital, Dept of Oncology, clinical trial unit182
进行中(未招募)
1 期
Avastin and chemotherapy followed by a KRAS stratified randomization to maintenance treatment for first line treatment of metastatic colorectal cancer - ACT2Patients with previously untreated metastatic colorectal carcinoma.MedDRA version: 14.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2010-019815-40-DKSkåne University Hospital, Department of Oncology230
进行中(未招募)
不适用
Avastin and chemotherapy followed by a KRAS stratified randomization to maintenance treatment for first line treatment of metastatic colorectal cancerPatients with previously untreated metastatic colorectal carcinoma.MedDRA version: 14.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2010-019815-40-SESkåne University Hospital, Department of Oncology230
已完成
4 期
Avastin in Combination With Chemotherapy for RAS Mutant Unresectable Colorectal Liver-limited MetastasesColorectal Neoplasms
NCT01972490Xu jianmin241
Unknown
3 期
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast CancerCardiac ToxicityPerioperative/Postoperative ComplicationsBreast Cancer
NCT01093235Cambridge University Hospitals NHS Foundation Trust800